Dr. Ryan Cole, an anatomic clinical pathologist with a subspecialty in skin pathology and postgraduate Ph.D. training in immunology, has been on the frontlines exposing the fraudulent COVID narrative.
Since 2004, he’s been operating his own business, a pathology laboratory, which gives him rare freedom and flexibility to comment on what he’s seeing. Most others would lose their jobs for speaking out the way Cole has.
Truth Telling Is a Risky Business
That doesn’t mean he hasn’t paid a price for speaking out about and defending real science though. He’s triple board certified and has 12 state licenses, and because of his stance against COVID recommendations, some of the credentialing organizations have taken action against him.
“I’ve seen 500,000 patients diagnostically in my career through the microscope. So, I have a long track record of diagnostics. I have not had a patient care complaint against me in 26 years of being a physician,” he says. “I still don’t, and this is what’s fascinating.
Of those 12 licenses, four were under attack, three are still under attack — in Washington, Arizona and Minnesota — [yet there’s] not a single patient care complaint. All the attacks against me have been political complaints to boards of medicine, which is not legal for them to do. Not a single one of those complaints is from a patient.
And then — really the most egregious thing — was ex parte, without me being present, without even sending a certified letter, the College of American Pathologists removed my fellowship status, which is defamatory.
I went back and found their complaint and looked at what they did, and I actually have a wonderful defamation lawsuit against them, because everything they did was anti-scientific. So, they can either restore [my fellowship] now, or just pay me a big check down the road. One or the other.”
He’s also lost about half of his business, as two insurance companies canceled him for “unprofessional behavior,” i.e., for sharing and discussing the science of COVID, and one of his best friends, whom he’s worked with for 12 years, canceled their business relationship as he didn’t want Cole’s outspokenness to affect his business. “All because of the defamation by the media, so to tell the truth in this day and age is a dangerous thing,” he says.
Suspicions Arose Early On
From his Ph.D. work in immunology, Cole was very aware of SARS-CoV-1 and MERS, having studied both, so when the warp speed program to develop a pandemic SARS-CoV-2 vaccine was announced, he became immediately suspicious.
“I thought, wait a minute, you can’t vaccinate against corona viruses!” he says. “This family of viruses is not amenable to vaccination, based on mutation rates. So, my concern was very high, early on.”
Cole’s lab ramped up PCR testing, using a cycle threshold (CT) of 35, rather than the recommended 40 to 45, as he knew that high a CT would result in 98% false positives. On a side note, pathologists not only assess tissue samples and biopsies, they’re also in charge of testing. The head of every major clinical lab is a pathologist. They’re basically in charge of quality control.
“As pathologist, we’re constantly looking at patterns, be it under the microscope or be it in lab data. We’re looking at blood reports. We’re looking at what’s out of range on blood reports. We’re looking at microbiology. We’re looking at molecular biology. We’re looking at cultures. We’re looking at pap smears. We’re looking, across the board, at those clinical parameters in addition to tissue biopsies,” he explains.
“I have 70 employees, and if there’s a blood smear that looks unusual, they bring it to me. If there are parameters on a test that look widely out of range, they bring it to me. And I call and talk to the clinician — [I’m the] doctor to the doctor. We have a consultation practice with the clinicians so I can help them understand what’s happening with their patient, and then they can make clinical decisions going forward.”
Post-Jab Cancer Explosion
One of the apparent side effects of the COVID jab that Cole has been warning and talking about is cancer. He explains:
“Obviously, during COVID, we saw some parameters change in blood tests. There was a concern about clotting. We saw elevated clotting factors. We know that the early variants were pretty severe in terms of inducing clotting, which was a shame because the whole world should have been simply using anti-inflammatories, steroids and anti-clotting agents, and so many more people would’ve lived.
My colleague, Dr. [Shankara] Chetty in South Africa, was having phenomenal success with antihistamine steroids and anti-clotting agents. So anyway, that first year, we saw drops in white blood cell counts, we saw decreases in certain subsets of T-cells. But when the shots rolled out, things changed.
At first I noticed kind of an innocuous little bump that we see usually in children. It’s a little virus called molluscum contagiosum [that causes] a little white bump.
Usually, by the time you’re a tween or early teen, you’ve built immunity to that and you never get them again, or rarely get them again. But after the shots rolled out, all of a sudden, in 80-year-olds, 70-year-olds, 60-year-olds, 50-year-olds, I started seeing literally a 20-fold increase in this little innocuous viral bump. And I thought, ‘Uh oh, this means they’ve lost immune memory’ …
Those subsets of T-cells that keep viruses in check are very important for keeping cancer in check. And this is where immunology jumps into the picture. All of us have some atypical cells, and we have the ‘Marines’ of our immune system, our natural killer (NK) cells. They’re on the frontline circulating. We have about 30 billion T-cells circulating in our blood, many of which are killer cells and NK cells.
Our other innate cells are our macrophages, monocytes and dendritic cells. They’re on that frontline. They’re shaking hands with every cell in your body all day long saying, ‘Friend or foe? Friend or foe? Oh gosh, this one has some mutations, it’s now a foe.’ They’ll poke a little hole in it, throw in a little enzyme called a grandzyme — a ‘hand grenade’ — blow up that cell, and we’re good.
But what happened after these shots rolled out is that many of those cell subsets started decreasing in number. The first cancer I saw uptick was cancers of the uterus, endometrial cancers. Usually, I would see maybe two endometrial cancers a month. All of a sudden, a few months after the rollout of the shots, I was seeing two or three a week.
Another subspecialty area of focus for me is melanoma. And I started seeing melanomas, not only in younger patients, as the shots dropped down in age cohort, but they were thicker. The other fascinating thing was they’re more aggressive in terms of how many dividing cells was present in each tumor. I’m still seeing this.
Beyond that … I’ve been traveling the country and the world quite a bit … and wherever I go now, I have doctors and nurses approach me saying, ‘What you’re saying, we’ve been seeing.’
I was having a conversation with a chair of a large oncology department in Tallahassee, and he said, ‘I usually see an aggressive brain cancer in a young patient maybe every decade.’ After the boosters rolled out, he saw five astrocytomas, five aggressive brain cancers, in one month.
Then, I’m in Jacksonville the next day, having a conversation with a family doctor. He said, ‘Gosh, it’s strange, I usually see a kidney cancer in a young patient every decade or so. I’ve seen five in the last month.’
Then I was in the UK a couple weeks ago. I had a doctor from Ireland who’s been a practicing family doc, GP, for 36 years, and he said, ‘I have seen more cancer in my young patients ever since the shots rolled out, and the booster, than I have ever seen in my entire career.’
Same thing, a nurse that works emergency department in the UK, [said she’s seen] not only the heart inflammation in young children, but cancers in young patients and aggressive leukemias. So everywhere I go, I have doctors confirming my observations … I’ve had many of them approach me and say, ‘Hey look, I’m seeing what you’re saying, but I can’t say it because I’ll get fired.'”
[...]
